All recombinant antibody production starts with a DNA sequence, meaning that a defined antibody will be produced, at a higher purity than traditional monoclonals, and with minimal batch-to-batch variation.
Using recombinant antibodies means researchers can reference completely defined reagents at the sequence level and provide the highest level of reproducibility for other scientists to reproduce and build on specific results. You can also navigate https://www.bosterbio.com/featured-products to know more about antibodies.
In addition, with the available sequences, engineers like Absolute Antibodies can take a step forward and tailor antibodies for various applications. Researchers have options available that are not possible with traditional monoclonal devices. Recombinant antibody technology has been around since the 1980s.
Image Source: Google
This technique allows us to easily change the type and form of antibodies, which gives researchers more options to consider reagents for their experiments or to compare antibodies with host organisms to reduce immunogenicity in vivo studies. Each recombinant antibody in the Absolute Antibody catalog is available in a variety of types and formats.
Major antibody manufacturers offer a range of recombinant products as part of their product offerings, but we are still the only antibody company to be exclusively recombinant.
The demand for recombinant antibodies is growing rapidly. Indeed, bispecific antibodies have been released in the clinic, with preclinical and clinical data showing potency well above that achieved with monospecific or combined antibody therapy.